发明名称 Use of Post-Transplant Cyclophosphamide Treated Allogeneic Marrow Infiltrating Lymphocytes to Augment Anti-Tumor Immunity
摘要 The present invention relates to the field of cancer therapy. More specifically, the present invention provides methods and compositions useful for augmenting anti-tumor immunity. In one embodiment, a method for treating or preventing post-allogeneic transplant relapse in a subject who has received post-transplant cyclophosphamide treatment comprises the steps of (a) obtaining a bone marrow sample from the subject; (b) expanding the marrow infiltrating lymphocytes (MILs) present in the sample; and (c) administering the MILs to the subject. In a specific embodiment, the method significantly reduces the likelihood of developing GVHD.
申请公布号 US2015320798(A1) 申请公布日期 2015.11.12
申请号 US201314647358 申请日期 2013.11.26
申请人 The Johns Hopkins University 发明人 Borrello Ivan M.;Noonan Kimberly A.;Luznik Leonido
分类号 A61K35/17;A61K31/675 主分类号 A61K35/17
代理机构 代理人
主权项 1. A method for treating or preventing post-allogeneic transplant relapse in a subject who has received post-transplant cyclophosphamide treatment comprising the steps of: a. obtaining a bone marrow sample from the subject; b. expanding the marrow infiltrating lymphocytes (MILs) present in the sample; and c. administering the MILs to the subject.
地址 Baltimore MD US